retatrutide clinical trial philippines Eli Lilly's sets new record for weight loss in obesity space Retatrutide, a GIP, GLP-1 and

: Redefining the market with dual GIP/GLP-1 innovation and exceptional glucose + weight management outcomes

SGLT2 inhibitors, commonly prescribed for type 2 diabetes, substantially increase the risk of genital mycotic infections due to their mechanism of increasing urinary glucose excretion

Thats likely because tirzepatide works on two hormone systems (GLP-1 and GIP), not just one

But correcting deficiencies in either can meaningfully improve energy levels, insulin sensitivity, and overall metabolic function, which aligns with what users taking tirzepatide with B12 or semaglutide with methylcobalamin also experience

For the most part, they're related to the weight loss itself